Cumberland Pharmaceuticals (CPIX) Short term Debt (2010 - 2024)
Cumberland Pharmaceuticals' (CPIX) quarterly Short term Debt came in at $5.1 million in Q4 2024, down 14.84% quarter-over-quarter from $6.0 million in Q3 2024.
Cumberland Pharmaceuticals (CPIX) Short term Debt (2010 - 2024) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Short term Debt across 4 years of filings, most recently posting $5.1 million for Q4 2024.
- Short term Debt for Q4 2024 came in at $5.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $5.1 million (changed N/A YoY), and the FY2024 annual result was $5.1 million, changed N/A from the prior year.
- Short term Debt came in at $5.1 million for Q4 2024 at Cumberland Pharmaceuticals, down from $6.0 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $6.0 million in Q3 2024 to a low of $2.0 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.10 Mn |
| Sep 30, 2024 | 5.99 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2011 | 4.00 Mn |
| Dec 31, 2010 | 2.67 Mn |